デフォルト表紙
市場調査レポート
商品コード
1617875

強度変調放射線治療市場:適応症、放射線タイプ、エンドユーザー別-2025~2030年の世界予測

Intensity Modulated Radiotherapy Market by Indication (Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer), Radiation Type (Carbon-Ion Radiation, Electron Radiation, Photon Radiation), End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
強度変調放射線治療市場:適応症、放射線タイプ、エンドユーザー別-2025~2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

強度変調放射線治療市場は、2023年に23億米ドルと評価され、2024年には24億3,000万米ドルに達すると予測され、CAGR 5.36%で成長し、2030年には33億2,000万米ドルになると予測されています。

強度変調放射線治療(IMRT)は、がん治療で使用される放射線療法の先進的形態であり、周囲の正常組織への被曝を最小限に抑えながら、悪性腫瘍または腫瘍内の特定領域に正確な放射線量を照射することに重点を置いています。IMRTの必要性は、がん治療における有効性と安全性のバランスを向上させ、ターゲティング精度を向上させ、副次的損傷を減少させる能力に由来します。その応用範囲は広く、前立腺がん、頭頸部がん、婦人科がん、肺がん、乳がん、消化器がんなど、さまざまな種類のがんに使用されています。最終用途の範囲には、主に病院、がん研究機関、専門の放射線治療センターが含まれます。

主要市場の統計
基準年[2023年] 23億米ドル
予測年[2024年] 24億3,000万米ドル
予測年[2030年] 33億2,000万米ドル
CAGR(%) 5.36%

市場洞察によると、IMRTの成長は、放射線治療の技術的進歩、がんの有病率の増加、低侵襲治療オプションに対する需要の高まりに大きく影響されています。最新の潜在的機会は、治療計画とリアルタイム適応放射線治療技術を強化するためのAIと機械学習の統合にあり、IMRTと共生的な技術革新を共有する陽子線治療と重粒子線治療の可能な開発と並んでいます。こうした機会を捉えるためには、次世代の放射線治療ソリューションへの道を開くためのハイテク企業との戦略的提携とともに、研究開発への投資が不可欠です。

しかし、IMRTを効果的に実施するための熟練した専門家が不足していることに加え、新興国市場での導入が制限されている機器の高コストなどの制約があります。さらに、技術革新のペースが速いため、継続的なトレーニングや教育が必要となり、リソースが集中する可能性があります。また、特に医療インフラが確立されていない地域では、規制上のハードルや償還の問題も課題として挙げられます。技術革新という点では、費用対効果の高い治療提供モデルへの注力、遠隔治療サービスの拡大、より広範なアクセスのためのポータブルIMRTシステムの開発などが、実行可能な成長経路を提供する可能性があります。同市場は、高い投資ニーズと急速な技術転換を主要特徴としており、イノベーションのための活気ある道であると同時に、新規参入企業にとっては実質的な参入障壁となっています。

市場力学:急速に進化する強度変調放射線治療市場の主要市場洞察を公開

強度変調放射線治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 世界のがん罹患率の増加
    • がん管理に対する政府のイニシアチブの高まり
    • 世界の医療支出の増加
  • 市場抑制要因
    • がん治療費の高騰
  • 市場機会
    • 強度変調放射線治療における継続的な技術革新
    • がん領域における革新的治療の採用拡大
  • 市場課題
    • 熟練した専門家の不足

ポーターのファイブフォース:強度変調放射線治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:強度変調放射線治療市場における外部からの影響の把握

外部マクロ環境要因は、強度変調放射線治療市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析:強度変調放射線治療市場における競合情勢の把握

強度変調放射線治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス:強度変調放射線治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、強度変調放射線治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨:強度変調放射線治療市場における成功への道筋を描く

強度変調放射線治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度:新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化:最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、地域はどこか?

3.市場を形成する主要技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中でがんの発生率が増加
      • がん管理に対する政府の取り組みの増加
      • 世界の医療費の増加
    • 抑制要因
      • がん治療の高額な費用
    • 機会
      • 強度変調放射線治療における継続的なイノベーション
      • 腫瘍学セグメントにおける革新的な治療の導入拡大
    • 課題
      • 熟練した専門家の不足
  • 市場セグメンテーション分析
    • 適応症:さまざまな適応症において副作用の軽減と患者の生活の質の向上を目的としたIMRTの適用が拡大
    • 放射線タイプ:さまざまな腫瘍のサイズ、場所、段階を治療するための多目的光子治療が優先
    • エンドユーザー:最新のイノベーションに投資する資金力のある病院による導入が増加
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境

第6章 強度変調放射線治療市場:適応症別

  • イントロダクション
  • 乳がん
  • 消化器がん
  • 婦人科がん
  • 肺がん
  • 前立腺がん

第7章 強度変調放射線治療市場:放射線タイプ別

  • イントロダクション
  • 炭素イオン放射線
  • 電子放射線
  • 光子放射
  • 陽子放射線

第8章 強度変調放射線治療市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 独立系放射線治療センター

第9章 南北アメリカの強度変調放射線治療市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の強度変調放射線治療市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの強度変調放射線治療市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
    • M42とQSTが炭素イオン治療に関する研究を共有する協定を締結
    • IBAは、世界中の腫瘍医に陽子線治療のトレーニングを提供するために、Apollo Proton Cancer Centreと独占的に提携
    • 英国初の乳がん陽子線治療検査開始
  • 戦略分析と提言

企業一覧

  • Accuray Incorporated
  • Aetna Inc.
  • Brainlab AG
  • Elekta AB
  • GE Healthcare
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • PMB by ALCEN group
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • Xstrahl Group
図表

LIST OF FIGURES

  • FIGURE 1. INTENSITY MODULATED RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTENSITY MODULATED RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTENSITY MODULATED RADIOTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY CARBON-ION RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY ELECTRON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PHOTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROTON RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-CF6C60CF95AB

The Intensity Modulated Radiotherapy Market was valued at USD 2.30 billion in 2023, expected to reach USD 2.43 billion in 2024, and is projected to grow at a CAGR of 5.36%, to USD 3.32 billion by 2030.

Intensity Modulated Radiotherapy (IMRT) is an advanced form of radiation therapy used in cancer treatment that focuses on delivering precise radiation doses to a malignant tumor or specific areas within the tumor while minimizing exposure to the surrounding normal tissues. The necessity of IMRT stems from its ability to improve targeting accuracy and reduce collateral damage, enhancing the balance between efficacy and safety in cancer therapeutics. Its application is extensive, being used for various types of cancer, including prostate, head and neck, gynecological, lung, breast, and gastrointestinal cancers. The end-use scope predominantly includes hospitals, cancer research institutes, and specialized radiotherapy centers.

KEY MARKET STATISTICS
Base Year [2023] USD 2.30 billion
Estimated Year [2024] USD 2.43 billion
Forecast Year [2030] USD 3.32 billion
CAGR (%) 5.36%

Market insights indicate that the growth of IMRT is significantly influenced by technological advancements in radiation therapy, increasing prevalence of cancer, and rising demand for less invasive treatment options. The latest potential opportunities lie in the integration of AI and machine learning to enhance treatment planning and real-time adaptive radiotherapy techniques, alongside possible developments in proton and heavy ion therapy, which share symbiotic technological innovations with IMRT. To seize these opportunities, investments in research and development are essential, along with strategic partnerships with tech companies to pave the way for next-generation radiotherapy solutions.

However, the market faces limitations such as the high cost of equipment, which restricts adoption in developing regions, alongside a scarcity of skilled professionals to effectively implement IMRT procedures. Additionally, the rapid pace of innovation necessitates continuous training and education, which can be resource-intensive. Challenges also include regulatory hurdles and reimbursement issues, particularly in regions with less established healthcare infrastructures. In terms of innovation, focusing on cost-effective treatment delivery models, expanding teletherapy services, and developing portable IMRT systems for broader access could offer viable growth pathways. The market is predominantly characterized by high investment needs and rapid technological transitions, presenting both a vibrant avenue for innovation and substantial entry barriers for new players.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intensity Modulated Radiotherapy Market

The Intensity Modulated Radiotherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of cancer across the world
    • Rise in government initiatives for cancer management
    • Increase in healthcare expenditure globally
  • Market Restraints
    • High cost of cancer treatment
  • Market Opportunities
    • Ongoing innovation in Intensity Modulated Radiotherapy
    • Growing adoption of innovative treatment in the oncology field
  • Market Challenges
    • Shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Intensity Modulated Radiotherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intensity Modulated Radiotherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intensity Modulated Radiotherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intensity Modulated Radiotherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intensity Modulated Radiotherapy Market

A detailed market share analysis in the Intensity Modulated Radiotherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intensity Modulated Radiotherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intensity Modulated Radiotherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intensity Modulated Radiotherapy Market

A strategic analysis of the Intensity Modulated Radiotherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intensity Modulated Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Aetna Inc., Brainlab AG, Elekta AB, GE Healthcare, Hitachi, Ltd., Mevion Medical Systems, PMB by ALCEN group, Siemens Healthineers AG, Varian Medical Systems, Inc., and Xstrahl Group.

Market Segmentation & Coverage

This research report categorizes the Intensity Modulated Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer, Lung Cancer, and Prostate Cancer.
  • Based on Radiation Type, market is studied across Carbon-Ion Radiation, Electron Radiation, Photon Radiation, and Proton Radiation.
  • Based on End-User, market is studied across Hospitals and Independent Radiotherapy Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer across the world
      • 5.1.1.2. Rise in government initiatives for cancer management
      • 5.1.1.3. Increase in healthcare expenditure globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cancer treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in Intensity Modulated Radiotherapy
      • 5.1.3.2. Growing adoption of innovative treatment in the oncology field
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Growing applications of IMRT for reduced side effects and enhanced quality of patient life across various indications
    • 5.2.2. Radiation Type: Higher preferences for versatile photon therapy to treat various tumor sizes, locations, and stages
    • 5.2.3. End-User: Rising adoption by hospitals with greater financial resources to invest in the latest innovations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intensity Modulated Radiotherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gastrointestinal Cancer
  • 6.4. Gynecological Cancer
  • 6.5. Lung Cancer
  • 6.6. Prostate Cancer

7. Intensity Modulated Radiotherapy Market, by Radiation Type

  • 7.1. Introduction
  • 7.2. Carbon-Ion Radiation
  • 7.3. Electron Radiation
  • 7.4. Photon Radiation
  • 7.5. Proton Radiation

8. Intensity Modulated Radiotherapy Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Radiotherapy Centers

9. Americas Intensity Modulated Radiotherapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intensity Modulated Radiotherapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intensity Modulated Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. M42 and QST Sign Agreement to Share Research on Carbon Ion Therapy
    • 12.3.2. IBA Partners Exclusively with Apollo Proton Cancer Centre for Providing Proton Beam Therapy Training to Oncologists from Across the Globe
    • 12.3.3. First UK Proton Beam Therapy Trial for Breast Cancer Launches
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Aetna Inc.
  • 3. Brainlab AG
  • 4. Elekta AB
  • 5. GE Healthcare
  • 6. Hitachi, Ltd.
  • 7. Mevion Medical Systems
  • 8. PMB by ALCEN group
  • 9. Siemens Healthineers AG
  • 10. Varian Medical Systems, Inc.
  • 11. Xstrahl Group